TAM
ITCI

Tocqueville Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Tocqueville Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28,130
Closed -$365K – 793
2019
Q2 		$365K Buy
28,130
+5,425
+24% +$69.6K ﹤0.01% 654
2019
Q1 		$277K Sell
22,705
-1,980
-8% -$25.3K ﹤0.01% 687
2018
Q4 		$281K Sell
24,685
-375
-1% -$6.05K ﹤0.01% 638
2018
Q3 		$544K Hold
25,060
– – 0.01% 606
2018
Q2 		$443K Buy
25,060
+7,500
+43% +$152K 0.01% 629
2018
Q1 		$370K Sell
17,560
-6,500
-27% -$127K ﹤0.01% 667
2017
Q4 		$348K Buy
24,060
+11,735
+95% +$181K ﹤0.01% 674
2017
Q3 		$194K Hold
12,325
– – ﹤0.01% 778
2017
Q2 		$153K Sell
12,325
-1,000
-8% -$11.6K ﹤0.01% 763
2017
Q1 		$217K Sell
13,325
-1,800
-12% -$26K ﹤0.01% 739
2016
Q4 		$228K Sell
15,125
-76,650
-84% -$1.08M ﹤0.01% 739
2016
Q3 		$1.4M Buy
91,775
+5,600
+6% +$226K 0.02% 460
2016
Q2 		$3.35M Buy
86,175
+8,500
+11% +$305K 0.04% 346
2016
Q1 		$2.16M Buy
77,675
+500
+0.6% +$16.7K 0.03% 392
2015
Q4 		$4.15M Buy
77,175
+10,400
+16% +$525K 0.06% 309
2015
Q3 		$2.67M Buy
+66,775
New +$2.18M 0.04% 393

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tocqueville Asset Management's ITCI Position: Q3 2019 in Review

Tocqueville Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2019, closing a stake of 28,130 shares — an estimated $365K sold.

Tocqueville Asset Management first reported a position in ITCI in Q3 2015 and held it in 16 quarters. The position peaked at $4.15M in Q4 2015. 126 funds tracked by Wall St. Rank hold ITCI as of Q3 2019.

  • Tocqueville Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 28,130 Intra-Cellular Therapies Inc. shares in Q3 2019, an estimated $365K.
  • Tocqueville Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 16 quarters.
  • Tocqueville Asset Management's Intra-Cellular Therapies Inc. position peaked at $4.15M in Q4 2015.
  • 126 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2019.

Based on Tocqueville Asset Management's 13F filing for Q3 2019, filed 31 Oct 2019.